Renoprotective effect of febuxostat on contrast-induced acute kidney injury in chronic kidney disease patients stage 3: randomized controlled trial

INTRODUCTION: Contrast-induced acute kidney injury (CI-AKI) is known to be a complication of using intravascular contrast injection. Unfortunately, it is associated with adverse outcomes such as prolonged length of hospitalization and increased burden of health care costs. So, we aimed to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarhan, Iman Ibrahim, Abdellatif, Yasser A., Saad, Rania Elsayed, Teama, Nahla Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035112/
https://www.ncbi.nlm.nih.gov/pubmed/36949408
http://dx.doi.org/10.1186/s12882-023-03114-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035112/
https://www.ncbi.nlm.nih.gov/pubmed/36949408
http://dx.doi.org/10.1186/s12882-023-03114-4

Ejemplares similares